Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Cooper Joseph Patrick
 2. Date of Event Requiring Statement (Month/Day/Year)
07/10/2006		 3. Issuer Name and Ticker or Trading Symbol
MEDICIS PHARMACEUTICAL CORP [MRX]
(Last)
(First)
(Middle)
8125 N. HAYDEN ROAD		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
EVP,Corp & Product Development
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

SCOTTSDALE, AZ 85258		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 31,200 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (2) 07/16/2005 07/16/2014 Common Stock 63,000 $ 38.45 D  
Employee Stock Option (3) 03/01/2007 03/01/2013 Common Stock 63,000 $ 23.01 D  
Employee Stock Option (4) 07/31/2004 07/31/2013 Common Stock 63,000 $ 29.2 D  
Employee Stock Option (5) 07/21/2006 07/21/2015 Common Stock 28,500 $ 32.41 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Cooper Joseph Patrick
8125 N. HAYDEN ROAD
SCOTTSDALE, AZ 85258		       EVP,Corp & Product Development  

Signatures

Joseph Cooper 07/19/2006
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes 4,000 shares received from a restricted stock lapse that occurred on 3/1/06. Includes 16,000 shares from Restricted Stock grant dated 3/1/03- Remaining vesting of 30% on 3/1/07 and 50% on 3/1/08. Includes 5,700 shares of Restricted Stock Grant vesting over 5 years on grant date beginning 7/21/2006- 10% year 1, 10% year 2, 20% year 3, 30% year 4, 30% year 5. Includes 5,500 shares Restricted Stock Grant Vesting over 5 years on grant date beginning 2/7/2007- 10% year 1, 10% year 2, 20% year 3, 30% year 4, 30% year 5.
(2) NQ Employee Stock Option vesting over 5 years on grant date beginning 7/16/2005. 10% year 1, 10% year 2, 20% year 3, 30% year 4, 30% year 5.
(3) NQ Employee Stock Option grant dated 3/1/03. Vesting 50% on 3/1/07 and 50% on 3/1/08.
(4) NQ Employee Stock Option vesting over 5 years on grant date beginning 7/31/2004. 10% year 1, 10% year 2, 20% year 3, 30% year 4, 30% year 5.
(5) NQ Employee Stock Option vesting over 5 years on grant date beginning 7/21/2006. 10% year 1, 10% year 2, 20% year 3, 30% year 4, 30% year 5.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.